Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine

被引:262
作者
Hecq, J
Deleers, M
Fanara, D
Vranckx, H
Amighi, K
机构
[1] Univ Libre Bruxelles, Lab Pharmaceut & Biopharmaceut, B-1050 Brussels, Belgium
[2] UCB Bioprod SA, Dept Proc Proc & Analyt Dev, B-1420 Braine lAlleud, Belgium
关键词
nanoparticles; drugs; high pressure homogenization; dissolution; crystalline state; nifedipine;
D O I
10.1016/j.ijpharm.2005.05.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Poorly water-soluble drugs such as nifedipine (NIF) (similar to 20 ltg/ml) offer challenging problems in drug formulation as poor solubility is generally associated to poor dissolution characteristics and thus to poor oral bioavailability. In order to enhance these characteristics, preparation of nifedipine nanoparticles has been achieved using high pressure homogenization. The homogenization procedure has first been optimized in regard to particle size and size distribution. Nanoparticles were characterized in terms of size, morphology and redispersion characteristics following water-removal. Saturation solubility and dissolution characteristics were investigated and compared to the un-milled commercial NIF to verify the theoretical hypothesis on the benefit of increased surface area. Crystalline state evaluation before and following particle size reduction was also conducted through differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD) to denote eventual transformation to amorphous state during the homogenization process. Through this study, it has been shown that initial crystalline state is maintained following particle size reduction and that the dissolution characteristics of nifedipine nanoparticles were significantly increased in regards to the commercial product. The method being simple and easily scaled up, this approach should have a general applicability to many poorly water-soluble drug entities. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:167 / 177
页数:11
相关论文
共 23 条
[1]   Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state [J].
Bayomi, MA ;
Abanumay, KA ;
Al-Angary, AA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 243 (1-2) :107-117
[2]   Characterization of nifedipine solid dispersions [J].
Cilurzo, F ;
Minghetti, P ;
Casiraghi, A ;
Montanari, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 242 (1-2) :313-317
[3]   Nanosuspensions of poorly soluble drugs -: reproducibility of small scale production [J].
Grau, MJ ;
Kayser, O ;
Müller, RH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 196 (02) :155-159
[4]   THE EFFECT OF PARTICLE-SIZE DISTRIBUTION ON DISSOLUTION RATE AND ORAL ABSORPTION [J].
HINTZ, RJ ;
JOHNSON, KC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 51 (01) :9-17
[5]   EFFECT OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN ON CRYSTALLIZATION AND POLYMORPHIC TRANSITION OF NIFEDIPINE IN SOLID-STATE [J].
HIRAYAMA, F ;
WANG, Z ;
UEKAMA, K .
PHARMACEUTICAL RESEARCH, 1994, 11 (12) :1766-1770
[6]  
Keymolen B., 2002, THERMOCHIM ACTA, V7093, P1
[7]  
KONDO N, 1993, CHEM PHARM BULL, V41, P737
[8]  
KONDO N, 1993, BIOL PHARM BULL, V16, P796
[9]   Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation [J].
Krause, KP ;
Müller, RH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 214 (1-2) :21-24
[10]   Effect of particle size on the available surface area of nifedipine from nifedipine-polyethylene glycol 6000 solid dispersions [J].
Lin, CW ;
Cham, TM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 127 (02) :261-272